Health
Pfizer says BNT162b2 vaccine is effective against new Covid strains – Pharmaceutical Business Review
Pfizer said that BNT162b2 has been found to be effective against a key mutation found in two highly transmissible strains of the SARS-CoV-2 virus.
Pfizer and BioNTech said that their Covid-19 vaccine BNT162b2 has been found to be effective against a key mutation found in two highly transmissible strains of the SARS-CoV-2 virus as per the results from an in vitro study.
The in vitro study, which was held by Pfizer and the University of Texas Medical Branch (UTMB), demonstrated that the antibodies from people subjected to the vaccine could effectively work against the rapidly spreading variants.
Reported initially in the UK and South Africa,…
-
Noosa News20 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
Noosa News10 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
Noosa News14 hours agoManjimup engineer turns previously wasted avocados into liquid gold
-
Noosa News9 hours agoPeter Dutton insists there’s enough water for his seven nuclear plants, contradicting shadow frontbencher